Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825294 | Clinical Therapeutics | 2015 | 13 Pages |
Abstract
The safety profile of IR/ER HB/APAP during extended use was consistent with those of other low-dose opioid/APAP combination products. IR/ER HB/APAP is intended for acute pain; its efficacy for relief of CNCP would require further evaluation in an active- or placebo-controlled study. ClinicalTrials.gov Identifier: NCT01722864.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yanping MD, Kenneth MD, Thomas PhD, Elizabeth BA, Michael J. MD, Yin MS, Jim L. PhD,